A recent study presented that elevated plasma concentrations of syndecan-1 and hyaluronan in patients with end-stage chronic kidney disease decreased three months after kidney transplantation, suggesting the regression of endothelial dysfunction [52]. Here, SDC1 is linked to chronic kidney disease.